Raymond James & Associates Trans Medics Group, Inc. Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 27,436 shares of TMDX stock, worth $2.94 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,436
Previous 23,444
17.03%
Holding current value
$2.94 Million
Previous $3.53 Million
21.98%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding TMDX
# of Institutions
416Shares Held
29.9MCall Options Held
1.19MPut Options Held
777K-
Vanguard Group Inc Valley Forge, PA3.6MShares$386 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$284 Million0.01% of portfolio
-
State Street Corp Boston, MA1.29MShares$138 Million0.01% of portfolio
-
Fil LTD Hamilton, D01.06MShares$113 Million0.13% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL956KShares$103 Million0.03% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $3.42B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...